Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/21068
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2021-07-05T11:26:59Z-
dc.date.available2021-07-05T11:26:59Z-
dc.date.issued1997-
dc.identifier.citationKimya, Y. vd. (1997). "Plasma interleukin-1 alpha, interleukin-1 beta and interleukin-1 receptor antagonist levels in pre-eclampsia". European Journal of Obstetrics & Gynecology and Reproductive Biology, 73(1), 17-21.tr_TR
dc.identifier.issn0301-2115-
dc.identifier.urihttps://doi.org/10.1016/S0301-2115(97)02698-5-
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0301211597026985-
dc.identifier.urihttps://www.ejog.org/article/S0301-2115(97)02698-5/fulltext-
dc.identifier.urihttp://hdl.handle.net/11452/21068-
dc.description.abstractThe values of plasma interleukin-1 alpha (IL-1 alpha), interleukin-1 beta (IL-1 beta) and interleukin-l receptor antagonist (IL-1ra) levels were evaluated as the markers of pre-eclampsia in 35 serial plasma samples from ten pregnant women who subsequently developed pre-eclampsia and in 74 plasma samples from 20 uncomplicated pregnancies, retrospectively. No correlation was found between plasma IL-1 alpha, IL-1 beta and IL-1ra levels, liver and renal function tests, thrombocyte and white blood cell counts, proteinuria, measured in all systolic and diastolic blood pressures and gestational weeks. Almost equal levels of IL-1 alpha and IL-1 beta were corresponding groups, but these were too few in number to statistically analyze. IL-1ra values were higher in the pre-eclampsia group than in the uncomplicated pregnancy group, at 20-25 and 31-35 gestational weeks significantly and 26-30 gestational weeks insignificantly and showed an increase during labor in both groups. It was found to have 58% positive predictivity, 100% negative predictivity, 50% specificity and 100% sensitivity at gestational weeks 20-25. According to these results, IL-1ra seems to be considered for its high negative predictivity in the exclusion of the probability of pre-eclampsia development during antenatal visits, but its plasma level is not correlated with the severity of the disease.en_US
dc.language.isoenen_US
dc.publisherElsevier Sci Irelanden_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectObstetrics & gynecologyen_US
dc.subjectInterleukin-1 betaen_US
dc.subjectReproductive biologyen_US
dc.subjectInterleukin-1 receptor antagonisten_US
dc.subjectPre-eclampsiaen_US
dc.subjectPregnancy-induced hypertensionen_US
dc.subjectInterleukin-1 alphaen_US
dc.subjectExpressionen_US
dc.subjectMacrophagesen_US
dc.subjectWomenen_US
dc.titlePlasma interleukin-1 alpha, interleukin-1 beta and interleukin-1 receptor antagonist levels in pre-eclampsiaen_US
dc.typeArticleen_US
dc.identifier.wosA1997XA44700004tr_TR
dc.identifier.scopus2-s2.0-0030612776tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Kadın Hastalıkları ve Doğum Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Mikrobiyoloji Anabilim Dalı.tr_TR
dc.identifier.startpage17tr_TR
dc.identifier.endpage21tr_TR
dc.identifier.volume73tr_TR
dc.identifier.issue1tr_TR
dc.relation.journalEuropean Journal of Obstetrics & Gynecology and Reproductive Biologyen_US
dc.contributor.buuauthorKimya, Yalçın-
dc.contributor.buuauthorAkdiş, Cezmi-
dc.contributor.buuauthorCengiz, Candan-
dc.contributor.buuauthorOzan, Hakan-
dc.contributor.buuauthorTatlıkazan, Serhat-
dc.contributor.buuauthorUncu, Gürkan-
dc.contributor.buuauthorŞengül, Ferah-
dc.contributor.researcheridF-4657-2014tr_TR
dc.identifier.pubmed9175684tr_TR
dc.subject.wosObstetrics & gynecologyen_US
dc.subject.wosReproductive biologyen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubmeden_US
dc.wos.quartileQ4 (Reproductive biology)en_US
dc.wos.quartileQ3 (Obstetrics & gynecology)en_US
Appears in Collections:Web of Science

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.